A. Fulghesu

发表

Effect of pituitary adenylate cyclase-activating peptide on meiotic maturation in follicle-enclosed, cumulus-enclosed, and denuded rat oocytes.

A. Lanzone, A. Caruso, R. Apa, 1997, Biology of reproduction.

Endocrino-metabolic features in women with polycystic ovary syndrome during pregnancy.

A. Lanzone, A. Caruso, S. Ferrazzani, 1998, Human reproduction.

Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome.

A. Lanzone, A. Caruso, A. Fulghesu, 1996, Human reproduction.

Polycystic ovary disease. A risk factor for gestational diabetes?

A. Lanzone, A. Caruso, N. Di Simone, 1995, The Journal of reproductive medicine.

Pituitary–ovarian response to the gonadotrophin‐releasing hormone‐agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma

A. Lanzone, G. Melis, S. Angioni, 2006, Clinical endocrinology.

Diagnosis of Polycystic Ovarian Syndrome in Adolescence

A. Fulghesu, C. Porru, E. Canu, 2018 .

Diagnosis of Metabolic Disorders in Women with Polycystic Ovary Syndrome

G. Melis, S. Angioni, F. Milano, 2008, Obstetrical & gynecological survey.

G. Melis, S. Angioni, L. Minerba, 2010, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

The quantitative insulin sensitivity check index is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome

G. Melis, S. Angioni, A. Fulghesu, 2011, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome.

A. Paoletti, G. Melis, S. Angioni, 2006, Fertility and sterility.

Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease.

A. Lanzone, A. Caruso, A. Fulghesu, 1998, Metabolism: clinical and experimental.

Effect of Maternal Carbohydrate Metabolism on Fetal Growth

A. Caruso, S. Ferrazzani, A. Fulghesu, 1998, Obstetrics and gynecology.

Heterogeneity in β cell activity , hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome

A. Lanzone, A. Caruso, A. Fulghesu, 1997 .

Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome.

F. Petraglia, A. Lanzone, A. Caruso, 1995, Fertility and sterility.

N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome.

A. Lanzone, L. Selvaggi, A. Fulghesu, 2002, Fertility and sterility.

Il-6 Serum Levels and Production Is Related to an Altered Immune Response in Polycystic Ovary Syndrome Girls with Insulin Resistance

A. Fulghesu, B. Batetta, E. Portoghese, 2011, Mediators of inflammation.

HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA)

F. Cirillo, C. Vezzani, M. Street, 2020, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome.

A. Lanzone, A. Caruso, A. Fulghesu, 1999, Metabolism: clinical and experimental.

Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome.

A. Fulghesu, F. Fruzzetti, R. Manca, 2015, Fertility and sterility.

Opioid Blockade Effect on Insulin β-Cells Secretory Patterns in Polycystic Ovary Syndrome

A. Lanzone, A. Fulghesu, M. Guido, 1998, Hormone Research in Paediatrics.

Opioid blockade effect on insulin beta-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus.

A. Lanzone, A. Fulghesu, M. Guido, 1998, Hormone research.

Acute insulin response to intravenous glucagon in polycystic ovary syndrome.

A. Lanzone, A. Caruso, R. Apa, 1998, Human reproduction.

Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome.

A. Lanzone, A. Caruso, R. Apa, 1998, The Journal of clinical endocrinology and metabolism.

Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome.

A. Lanzone, A. Caruso, A. Fulghesu, 1999, Fertility and sterility.

Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study.

R. Pasquali, A. Gambineri, A. Lanzone, 2012, Human reproduction.

Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.

A. Lanzone, A. Caruso, R. Apa, 1990, Human reproduction.

Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome.

A. Lanzone, A. Caruso, A. Fulghesu, 1999, Human reproduction.

Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion.

A. Lanzone, A. Caruso, A. Fulghesu, 1992, Fertility and sterility.

Serum CA-125 levels do not depend on ovarian steroidogenesis.

A. Lanzone, A. Caruso, A. Fulghesu, 1990, Fertility and sterility.

Long-Term Naltrexone Treatment Reduces the Exaggerated Insulin Secretion in Patients With Polycystic Ovary Disease

A. Lanzone, A. Caruso, A. Fulghesu, 1993, Obstetrics and gynecology.

The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7‐fold increased risk of polycystic ovary syndrome in a Sardinian population

A. Farcomeni, C. Carcassi, F. Tiziano, 2012, Clinical endocrinology.

Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: A pilot prospective study

A. Caruso, R. Apa, A. Fulghesu, 2001, Journal of endocrinological investigation.

The hypothalamic-pituitary-luteal axis in women: Effects of long-term orally active opioid antagonist (naltrexone) administration

A. Lanzone, A. Caruso, R. Apa, 1997, Journal of endocrinological investigation.

Continuous subcutaneous insulin infusion (CSII) in pregnant diabetic women.

A. Lanzone, A. Caruso, A. Fulghesu, 1986, Acta endocrinologica. Supplementum.

Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome.

A. Lanzone, A. Caruso, A. Fulghesu, 1997, Fertility and sterility.

Insulin secretion in patients with gestational diabetes: relationship with pregnancy outcome.

A. Lanzone, A. Caruso, N. Di Simone, 1994, Hormone research.

Insulin and GH secretion in adolescent girls with irregular cycles: Polycystic vs multifollicular ovaries

A. Lanzone, R. Apa, A. Fulghesu, 2003, Journal of endocrinological investigation.

The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside—A Systematic Literature Review

S. Vitale, Li-Te Lin, T. Sathyapalan, 2022, Biomedicines.

Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome.

A. Lanzone, A. Caruso, A. Fulghesu, 1997, Human reproduction.

Indomethacin in vivo inhibits the enhancement of the progesterone secretion in response to gonadotrophin-releasing hormone by human corpus luteum.

A. Lanzone, A. Caruso, N. Di Simone, 1993, Human reproduction.

Human growth hormone enhances progesterone production by human luteal cells in vitro: evidence of a synergistic effect with human chorionic gonadotropin.

A. Lanzone, A. Caruso, N. Di Simone, 1992, Fertility and sterility.

Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.

A. Lanzone, L. Selvaggi, M. Giuliani, 2010, Fertility and sterility.

Polycystic Ovarian Morphology in Normocyclic Non-Hyperandrogenic Adolescents.

A. Gambineri, A. Fulghesu, E. Canu, 2021, Journal of pediatric and adolescent gynecology.

Very low dose of flutamide in the treatment of hyperandrogenism

G. Melis, A. Fulghesu, E. Canu, 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Assessment of the adrenal-ovarian contribution by short-term dexamethasone and ACTH tests in hyperandrogenized patients.

A. Lanzone, A. Caruso, R. Apa, 1991, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Effect of corticotropin-releasing factor on the pituitary-ovary axis in human luteal phase.

A. Lanzone, A. Caruso, R. Apa, 1995, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Multiple serum marker assay in the diagnosis of endometriosis.

A. Lanzone, A. Caruso, A. Fulghesu, 1992, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: relationship with insulin and luteinizing hormone secretion.

A. Lanzone, A. Caruso, A. Fulghesu, 1995, The Journal of clinical endocrinology and metabolism.

Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease.

A. Lanzone, A. Caruso, A. Fulghesu, 1995, Fertility and sterility.

Endocrinology: Effect of opioid blockade on insulin metabolism in polycystic ovarian disease

A. Lanzone, A. Caruso, A. Fulghesu, 1995 .

Long-term naltrexone treatment normalizes the pituitary response to gonadotropin-releasing hormone in polycystic ovarian syndrome.

A. Lanzone, A. Caruso, R. Apa, 1993, Fertility and sterility.

Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease.

A. Lanzone, A. Caruso, N. Di Simone, 1991, Human reproduction.

Comment on "Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome".

A. Lanzone, A. Fulghesu, M. Ciampelli, 1999, The Journal of clinical endocrinology and metabolism.

Ovarian sensitivity to follicle-stimulating hormone during the follicular phase of the human menstrual cycle and in patients with polycystic ovarian syndrome.

A. Lanzone, A. Caruso, A. Fulghesu, 1993, Fertility and sterility.

Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease.

A. Lanzone, A. Caruso, R. Apa, 1987, The Journal of clinical endocrinology and metabolism.

Multiple serum diagnosis of endometriosis marker assay in

S. Cuore, A. Fulghesu, F. Cucinelli, 1992 .

The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome.

A. Lanzone, A. Caruso, R. Apa, 1997, The Journal of clinical endocrinology and metabolism.

LH surge induction by GnRH agonist at the time of ovulation.

A. Lanzone, A. Caruso, R. Apa, 1989, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Luteal responses to gonadotropin-releasing hormone during the luteal phase: relation to the age of corpus luteum.

A. Lanzone, A. Caruso, A. Fulghesu, 1987, The Journal of clinical endocrinology and metabolism.

Recombinant versus Urinary Follicle-Stimulating Hormone in the Low-Dose Regimen in Anovulatory Patients with Polycystic Ovary Syndrome: A Safer and More Effective Treatment

A. Lanzone, A. Caruso, R. Apa, 2001, Hormone Research in Paediatrics.

Urinary Metabolites Reveal Hyperinsulinemia and Insulin Resistance in Polycystic Ovarian Syndrome (PCOS)

L. Atzori, A. Dessì, V. Fanos, 2021, Metabolites.

Good Practice in Pediatric and Adolescent Gynecology

A. Fulghesu, 2017, Springer International Publishing.

Ovulation induction in young girls with menometrorragia: a safe and effective treatment

A. Fulghesu, C. Porru, R. Magnini, 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Ultrasound diagnosis of polycystic ovarian syndrome: current guidelines, criticism and possible update

A. Fulghesu, Anna Maria Fulghesu, Elena Canu, 2017 .

Growth hormone enhances estradiol production follicle-stimulating hormone-induced in the early stage of the follicular maturation.

A. Lanzone, A. Caruso, A. Fulghesu, 1996, Fertility and sterility.

Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles.

A. Lanzone, A. Caruso, A. Fulghesu, 1994, Fertility and sterility.

Evidence of a disturbance of the hypothalamic‐pltuitary‐adrenal axis in polycystic ovary syndrome: effect of naloxone

A. Lanzone, A. Caruso, A. Fulghesu, 1996, Clinical endocrinology.

An open multicenter study to compare the efficacy of intraperitoneal insemination and intrauterine insemination following multiple follicular development as treatment for unexplained infertility

S. Guerriero, A. Lanzone, S. Ajossa, 2007, Journal of Assisted Reproduction and Genetics.

CLINICAL ASSISTED REPRODUCTION An Open Multicenter Study to Compare the Efficacy of Intraperitoneal Insemination and Intrauterine Insemination Following Multiple Follicular Development as Treatment for Unexplained Infertility 1

S. Guerriero, A. Lanzone, S. Ajossa, 1997 .

A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio.

A. Lanzone, R. Apa, A. Fulghesu, 2001, Fertility and sterility.

Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?

A. Lanzone, L. Selvaggi, R. Apa, 2006, Human reproduction.

Effect of gonadotrophin-releasing hormone and related analogue on human luteal cell function in vitro.

A. Lanzone, A. Caruso, N. Di Simone, 1989, Human reproduction.

Effect of Maternal Carbohydrate Metabolism on Fetal Growth

A. Caruso, S. Ferrazzani, A. Fulghesu, 1998, Obstetrics and gynecology.

The growth hormone response to growth hormone-releasing hormone is blunted in polycystic ovary syndrome: relationship with obesity and hyperinsulinaemia.

A. Lanzone, A. Caruso, A. Fulghesu, 1995, Human reproduction.

The effect of age on the ovarian response to gonadotropin and on pregnancy rate in polycystic ovary syndrome

A. Lanzone, L. Selvaggi, R. Apa, 2003, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Ultrasound in polycystic ovary syndrome--the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study.

A. Lanzone, G. Melis, S. Angioni, 2007, Human reproduction.

Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Their relationships with hyperinsulinism and hyperandrogenism.

A. Lanzone, A. Caruso, S. Pappalardo, 1990, Gynecologic and obstetric investigation.

Hirsutism and hyperandrogenism associated with hyperreactio luteinalis in a singleton pregnancy: A case report

G. Melis, S. Angioni, F. Milano, 2007, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.

A. Lanzone, A. Caruso, A. Fulghesu, 1992, The Journal of reproductive medicine.

Induction of ovulation by intermittent intravenous purified follicle-stimulating hormone in polycystic ovarian disease.

A. Lanzone, A. Caruso, R. Apa, 1987, Fertility and sterility.

The impact of dosage on ovulation induction by pulsatile gonadotropin-releasing hormone (Gn-RH) in hypothalamic amenorrhea

A. Lanzone, A. Caruso, A. Fulghesu, 1987, Journal of endocrinological investigation.

Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients.

L. Marinis, A. Lanzone, A. Caruso, 1997, Metabolism: clinical and experimental.

Continuous subcutaneous insulin infusion (CSII) in pregnant diabetic patients

A. Lanzone, A. Caruso, A. Fulghesu, 1987, Prenatal diagnosis.

Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome.

U. Pagotto, R. Pasquali, A. Gambineri, 2010, The Journal of clinical endocrinology and metabolism.

Diagnosis of Metabolic Disorders in Women with Polycystic Ovary Syndrome

G. Melis, S. Angioni, F. Milano, 2008, Obstetrical & gynecological survey.